JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 11, 2003; DOI: 10.1124/jpet.103.056606


0022-3565/03/3072-737-744$20.00
JPET 307:737-744, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.056606v1
307/2/737    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beumer, C.
Right arrow Articles by Seinen, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beumer, C.
Right arrow Articles by Seinen, W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Bacterial Infections

INFLAMMATION AND IMMUNOPHARMACOLOGY

Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-Mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets

Chantal Beumer, Marty Wulferink, Willem Raaben, Daniëlle Fiechter, Ruud Brands, and Willem Seinen

Institute for Risk Assessment Sciences, University Utrecht, Utrecht, The Netherlands (C.B., M.W., W.R., D.F., R.B., W.S.); and AM-Pharma Holding BV, Bunnik, The Netherlands (M.W., W.R., R.B.)

It has been demonstrated that human placental alkaline phosphatase (HPLAP) attenuates the lipopolysaccharide (LPS)-mediated inflammatory response, likely through dephosphorylation of the lipid A moiety of LPS. In this study, it is demonstrated that also alkaline phosphatase derived from calf intestine (CIAP) is able to detoxify LPS. In mice administered CIAP, 80% of the animals survived a lethal Escherichia coli infection. In piglets, previous to LPS detoxification, the pharmacokinetic behavior of CIAP was studied. CIAP clearance was shown to be dose-independent and showed a biphasic pattern with an initial t1/2 of 3 to 5 min and a second phase t1/2 of 2 to 3 h. Although CIAP is cleared much faster than HPLAP, it attenuates LPS-mediated effects on hematology and tumor necrosis factor-{alpha} responses at doses up to 10 µg/kg in piglets. LPS-induced hematological changes were antagonized, and the tumor necrosis factor-{alpha} response was reduced up to 98%. Daily i.v. bolus administration of 4000 units CIAP, the highest dose used in the LPS intervention studies, in piglets for 28 days was tolerated without any sign of toxicity. Therefore, CIAP potentially encompasses a novel therapeutic agent in the treatment of LPS-mediated diseases. Based on the data mentioned above, human clinical trials have been initiated.


Received for publication July 4, 2003
Accepted July 31, 2003.

Address correspondence to: Prof. W. Seinen, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3508 TD, The Netherlands. E-mail: w.seinen{at}iras.uu.nl




This article has been cited by other articles:


Home page
Poult. Sci.Home page
D. Wang, X. Zhou, R. She, J. Xiong, Q. Sun, K. Peng, L. Liu, and Y. Liu
Impaired intestinal mucosal immunity in specific-pathogen-free chickens after infection with very virulent infectious bursal disease virus
Poult. Sci., August 1, 2009; 88(8): 1623 - 1628.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. Short
Microvilli give gut vesicles the brush-off
J. Cell Biol., June 29, 2009; 185(7): 1131 - 1131.
[Full Text] [PDF]


Home page
JCBHome page
R. E. McConnell, J. N. Higginbotham, D. A. Shifrin Jr., D. L. Tabb, R. J. Coffey, and M. J. Tyska
The enterocyte microvillus is a vesicle-generating organelle
J. Cell Biol., June 29, 2009; 185(7): 1285 - 1298.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Tuin, K Poelstra, A de Jager-Krikken, L Bok, W Raaben, M P Velders, and G Dijkstra
Role of alkaline phosphatase in colitis in man and rats
Gut, March 1, 2009; 58(3): 379 - 387.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. F. Goldberg, W. G. Austen Jr., X. Zhang, G. Munene, G. Mostafa, S. Biswas, M. McCormack, K. R. Eberlin, J. T. Nguyen, H. S. Tatlidede, et al.
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition
PNAS, March 4, 2008; 105(9): 3551 - 3556.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Shao, M. Lu, S. C. Katz, A. W. Varley, J. Hardwick, T. E. Rogers, N. Ojogun, D. C. Rockey, R. P. DeMatteo, and R. S. Munford
A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen
J. Biol. Chem., May 4, 2007; 282(18): 13726 - 13735.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Q. van Veen, A. K. van Vliet, M. Wulferink, R. Brands, M. A. Boermeester, and T. M. van Gulik
Bovine Intestinal Alkaline Phosphatase Attenuates the Inflammatory Response in Secondary Peritonitis in Mice
Infect. Immun., July 1, 2005; 73(7): 4309 - 4314.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
R. S. Munford
Invited review: Detoxifying endotoxin: time, place and person
Innate Immunity, April 1, 2005; 11(2): 69 - 84.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.